Home | Contact | Sitemap | Restricted area
GLP guideline
OECD "Principles of good laboratory practice regulations" C(97)186, (Official Journal European Communities 1999; 42: L77, 8-21)
http://www.oecd.org/document/63/0,2340,en_2649_34381_2346175_1_1_1_37465,00.html
OECD “Series on principles of good laboratory practice and compliance monitoring - Number 1”
OECD Principles on Good Laboratory Practice (ENV/MC/CHEM(98)17)
OECD "Series on principles of good laboratory practice and compliance monitoring - Number 13"
FDA "Good Laboratory Practices (GLP) under 21 CFR 58 applies to nonclinical laboratory studies" :
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=58
FDA "Bioanalytical Method Validation" (of May 2001) :
http://www.fda.gov/cder/guidance/4252fnl.pdf
FDA "Electronic Records; Electronic Signatures - Scope and Application" (Guidance for Industry - 21 CRF Part 11) :
http://www.fda.gov/cder/guidance/5667fnl.pdf
EEC "Harmonisation of laws, regulations and administrative provisions relating to the application of the principles of good laboratory practice and the verification of their applications for tests on chemical substances" (DIRECTIVE 2004/10/EC of the European Parliament and of the Council)
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:050:0044:0059:EN:PDF
French decision "GLP on chemicals" (Journal Officiel de la République Française n°282, page 18324, texte n° 14) http://www.legifrance.gouv.fr/WAspad/UnTexteDeJorf?numjo=INDI0630099D
French decision "GLP on drugs and cosmetics" (Journal Officiel de la République Française 2000; 132: 4465) http://afssaps.sante.fr/htm/3/indbpl.htm

Copyright 2008 © Iris Pharma - Conception CKC-Net.com






